Spencer Heaton

CEO at Espervita Therapeutics

Speaker

Dr. Heaton is a physician-executive with broad experience across various healthcare industries, including drug development, healthcare delivery, technology services, and molecular diagnostics. He is the CEO of Espervita Therapeutics, where he leads the development of a pipeline addressing metabolic disorders.

As Chief Medical & Commercial Officer for Lynx Dx, he has overseen the commercial launch of two urine-based molecular diagnostic tests that predict the personalized risk of clinically significant prostate cancer.

Dr. Heaton holds an MD from the University of Michigan Medical School and an MBA from the University of Michigan Ross School of Business. He completed residency in anesthesiology at the University of Michigan and a fellowship in pain medicine at Johns Hopkins University School of Medicine.